The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent and selective xanthine-based inhibitors of phosphodiesterase 5.EBI
Novartis Institutes of Biomedical Research
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.EBI
Novartis Institutes of Biomedical Research
Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.EBI
Novartis Institutes of Biomedical Research
Design and synthesis of a library of chemokine antagonists.EBI
Novartis Institutes of Biomedical Research
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.EBI
Novartis Institutes of Biomedical Research
4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.EBI
Novartis Institutes of Biomedical Research
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.EBI
Novartis Institutes of Biomedical Research